Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FX006 vs Kenalog-40 in Post-Traumatic Osteoarthritis of the Knee
NCT02468583Phase 2Terminated
- Sponsor
- Pacira BioSciences
- Start
- Feb 2015
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in Post-traumatic osteoarthritis (PTOA), sponsored by Pacira BioSciences. Started Feb 2015; status: terminated.
02
Drugs
triamcinolone acetonide
03
Conditions
Post-traumatic osteoarthritis (PTOA)
Beyond the preview
Go deeper on NCT02468583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468583.